Peripheral neuropathy and Guillain-Barré syndrome associated with fluoroquinolones

Peripheral neuropathy and Guillain-Barré syndrome associated with fluoroquinolones

Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis.

 

Add a Comment

Your email address will not be published. Required fields are marked *

Optin Architect